Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (10,726,658)	$ (10,603,477)	$ (10,849,169)	$ (9,659,918)	$ (29,658,032)	$ (32,043,982)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense					5,204,005	6,259,464
Issuance of shares in consulting agreement					267,000	610,000
Amortization of debt discount	305,125		158,397		859,135	391,920
Depreciation expense					15,654	12,624
Operating lease expense					0	160,685
Finance lease depreciation expense					29,010	30,297
Changes in assets and liabilities:
Prepaid expenses and other assets					114,499	73,205
Accounts payable					(5,681,904)	4,147,277
Accrued expenses					2,054,849	(4,580,981)
Operating lease liabilities					0	(239,469)
Net cash used in operating activities					(26,795,784)	(25,178,960)
Cash flows from investing activities:
Purchase of equipment					(29,000)	0
Net cash used in investing activities					(29,000)	0
Cash flows from financing activities:
Proceeds from exercise of stock options					629,591	8,849
Payments of finance lease obligations					(41,366)	(46,129)
Proceeds from issuance of common stock, net of issuance costs					19,427,294	5,647,467	$ 16,100,000
Net cash provided by financing activities					20,015,519	5,610,187
Net decrease in cash and cash equivalents					(6,809,265)	(19,568,773)
Cash and cash equivalents at beginning of period		$ 56,560,517		$ 73,820,160	56,560,517	73,820,160	73,820,160
Cash and cash equivalents at the end of period	$ 49,751,252		$ 54,251,387		49,751,252	54,251,387	$ 56,560,517
Supplemental information of cash and non-cash transactions:
Cash paid for interest					$ 2,721,354	$ 2,624,653